Navigation Links
Catherine Dulac, Cori Bargmann are co-recipients of 11th Perl-UNC Neuroscience Prize
Date:4/12/2011

said Dr. William Snider, director of the UNC Neuroscience Center and head of the selection committee for the prize.

School of Medicine Dean William L. Roper, MD, MPH, will present Dr. Dulac's share of the award at 11:45 a.m. April 21 in room G202 in the Medical Biomolecular Research Building on the UNC-Chapel Hill campus. Dr. Dulac will deliver her Perl Prize lecture immediately following the ceremony.

Dr. Bargmann will deliver her Perl Prize lecture at the 12th Annual UNC Neuroscience Symposium on Oct. 13 and receive her share of the award then.


'/>"/>

Contact: Les Lang
llang@med.unc.edu
919-966-9366
University of North Carolina School of Medicine
Source:Eurekalert  

Page: 1 2

Related biology news :

1. The American Society for Microbiology honors Catherine A. Blish
2. Neuroinformatics special issue spotlights the Neuroscience Information Framework
3. NTU, University of Warwick to collaborate in neuroscience research
4. Elseviers BrainNavigator research tool to launch new features at Neuroscience 2009 show
5. European Research Council grant for neuroscience research
6. Stanfords Hank Greely puts neuroscience on trial
7. Neuroscientist Robert H. Wurtz receives the $500,000 Gruber neuroscience prize
8. The neurosciences and music -- IV learning and memory
9. Media registration opens for Neuroscience 2010
10. 23rd ECNP Congress: Pioneering CNS research -- translating neuroscience into clinical progress
11. NIH grant to increase diversity in field of neuroscience
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Catherine Dulac, Cori Bargmann are co-recipients of 11th Perl-UNC Neuroscience Prize
(Date:5/18/2015)... -- Fingerprint Cards (FPC) has received an order ... FPC1035 from one if its module partners. Deliveries are planned ... and the sensors will be used by smartphone manufacturers in ... hereby amount to 740 MSEK to date. In addition to ... a number of smaller orders not separately communicated amounting to ...
(Date:5/11/2015)... Curemark LLC, a privately held drug research ... Phase III double blind, randomized, placebo-controlled clinical trial to ... all children ages 3-8 with Autism. Previously, Curemark announced ... blinded clinical trial for CM-AT in children ages 3-8 ... enzyme chymotrypsin. This new trial will help determine whether ...
(Date:5/5/2015)... Conn. , May 5, 2015, NXT-ID, Inc. ... authentication company focused on the growing mobile commerce market, reminds ... Company,s Chief Technology Officer, is presenting  at CARTES SECURE CONNEXIONS ... May 5-7, 2015. The three-day conference is ... David is speaking in is themed Global Fraud: Where ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3
... in the Proceedings of the National Academy of Sciences ... from the Kennedy Krieger Institute and four collaborating institutions, identified ... to the development of glaucoma and its resulting vision loss. ... head, the point where the cables that carry information from ...
... researchers led by Daniel J. Rader, MD, associate ... and Therapeutics, has received a $6 million grant ... molecular genetics of atherosclerotic cardiovascular disease. The team,s ... Plasma Lipids and Cardiovascular Disease," was selected to ...
... vomiting hairballs or refusing to eat probably isn,t being finicky ... is a good chance that the cat is acting sick ... new research suggests. Healthy cats were just as likely ... leave waste outside their litter box in response to changes ...
Cached Biology News:New research reveals unexpected biological pathway in glaucoma 2Penn Medicine researcher receives $6 million grant for cardiovascular disease study 2Even healthy cats act sick when their routine is disrupted 2Even healthy cats act sick when their routine is disrupted 3Even healthy cats act sick when their routine is disrupted 4Even healthy cats act sick when their routine is disrupted 5
(Date:5/29/2015)... The Academy of Model Aeronautics has awarded $46,500 ... across the nation. , The Academy of Model Aeronautics ... Members with scholarships to pursue technical careers. Since its ... nearly $900,000 to college-bound aero-modelers. The scholarships are granted ... AMA member donations, a portion of AMA member dues ...
(Date:5/29/2015)... , May 29, 2015 Delcath Systems, ... and medical device company focused on oncology with ... metastatic liver cancers, announces that results of a ... uveal melanoma patients with hepatic metastases with the ... highlighted in an on-line abstract at the American ...
(Date:5/29/2015)... 2015  Caris Life Sciences ® , a ... of precision medicine, today announced the presentation of ... utility of Caris Molecular Intelligence ® , the ... to identify targeted treatment options for patients with ... studies, results of which are to be presented ...
(Date:5/29/2015)... May 29, 2015 Results from a ... laherparepvec and its ability to reduce the size of ... been published in the Journal of Clinical Oncology. ... stages IIIB, IIIC and IV melanoma, a potentially fatal ... study was to evaluate the safety and efficacy of ...
Breaking Biology Technology:Academy of Model Aeronautics Awards $46,500 in Scholarships to College-Bound Model Aviation Pilots 2Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 2Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 3Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 4Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 5Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 2Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 3Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 4Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 5Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 6Study Published in Journal of Clinical Oncology Reports Talimogene Laherparepvec Improvesdurable Responses in Patients with Advanced Melanoma 2
... Aida,Pharmaceuticals, Inc. (OTC Bulletin Board: AIDA) today announced an ... to be launched by,the Company into the China market. ... I tests in July 2006, which consists of tests,for ... tested in,Phases II & III. Aida is currently undergoing ...
... and DETROIT, Oct. 22 The Michigan Life,Science ... rapidly,stimulate new business for Michigan companies. (Photo: ... BioPharma Company, LLC and the Michigan Virtual,Medical Device ... exhibit during,the MichBio Expo convention in Lansing, Michigan. ...
... Highlight and ... of Advanced Practices by Leading, Interventionalists, Broadcast from Around the World. - Hear About ... Stent, Results. - See How Many of the Major Fixed Imaging and Stent Manufacturers ... are Embracing IVUS., ...
Cached Biology Technology:Aida's Rh-Apo2L Clinical Testing Shows Preliminary Efficacy in Helping to Treat Lung Cancer, Stomach Cancer, Lymphoma, Pancreatic Cancer & Kidney Cancer 2Aida's Rh-Apo2L Clinical Testing Shows Preliminary Efficacy in Helping to Treat Lung Cancer, Stomach Cancer, Lymphoma, Pancreatic Cancer & Kidney Cancer 3Virtual Life Science Companies Launch and Tour 2Virtual Life Science Companies Launch and Tour 3Volcano Announces Activities at TCT 2007: Expanded Role of IVUS in PCI to be Demonstrated 2Volcano Announces Activities at TCT 2007: Expanded Role of IVUS in PCI to be Demonstrated 3Volcano Announces Activities at TCT 2007: Expanded Role of IVUS in PCI to be Demonstrated 4
Request Info...
... Accurate To score SNPs, ... sequencing, the gold standard in DNA analysis. ... The polymorphic locus can be confirmed by ... DNA sequencing also provides sequence context information, ...
... top-of-the-line PowerPac 3000 power supply is ... ideal for isoelectric focusing, DNA sequencing, ... electrophoresis, western blotting, and submerged gel ... of powre, the PowerPac 3000 power ...
... GT cell and PowerPac basic power supply are ... acids in agarose gels. The wide mini format ... and electrodes, and leveling bubble. The PowerPac basic ... of 10-300 V, 4-400 mA, and 75 W. ...
Biology Products: